“Levi and Korsinsky Launch Investigation into Potential Securities Fraud by Atara Biotherapeutics Inc. (ATRA)”
Levi & Korsinsky Investigates Atara Biotherapeutics, Inc. for Possible Securities Law Violations Investigation Details NEW YORK, NY / ACCESS Newswire / January 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Atara Biotherapeutics, Inc. (“Atara Biotherapeutics, Inc.”) (NASDAQ:ATRA) concerning possible violations of federal securities laws. Atara issued a press…